Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04471896 · ClinicalTrials.gov registry record · NA
Joovvin' for Your Skin Health Study
A NA study of Eczema and Acne, sponsored by ProofPilot.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT04471896: Completed NA study of Eczema and Acne, sponsored by ProofPilot.
NCT04471896 is a NA study of Eczema and Acne that has completed, run by ProofPilot. The registered enrollment target is 63 participants, below the 204-participant average among 29 other Eczema trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04471896, a NA study of Eczema and Acne, has completed, sponsored by ProofPilot.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
Sixty day single arm trial examining self-report and remote dermatology assessment of cosmetic skin health after daily 10-20 minute sessions with an infrared light therapy device (the Joovv Mini)
Primary Outcome
Comparison over timepoints of physician assessment of facial features at rest and smile to the Glogau \& custom wrinkle selfie scale
Conditions Studied
Interventions
- DEVICE Joovv Mini
Study Locations (1)
New York
- ProofPilot (Virtual Study: https://p.proofpilot.com) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2021-02-01 |
| Phase | NA |
What the finished NCT04471896 record still lists
NCT04471896 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 204-participant average among 29 other Eczema trials with a reported enrollment target (69% lower).
The record links to 6 conditions, with Eczema appearing as the primary indexed condition, and to 1 intervention - of which Joovv Mini is the first listed.
NCT04471896 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04471896 about?
NCT04471896 is a clinical study titled "Joovvin' for Your Skin Health Study". Sixty day single arm trial examining self-report and remote dermatology assessment of cosmetic skin health after daily 10-20 minute sessions with an infrared light therapy device (the Joovv Mini)
What is the current status of trial NCT04471896?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2020-08-01. Estimated completion is 2021-02-01.
What conditions does trial NCT04471896 study?
This clinical trial studies the following conditions: Eczema, Acne, Skin Diseases, Skin Inflammation, Skin Condition.
What interventions are being tested in trial NCT04471896?
The interventions under investigation include: Joovv Mini (DEVICE).
Who is sponsoring clinical trial NCT04471896?
This trial is sponsored by ProofPilot, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04471896 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eczema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04471896's enrollment target sits among peer trials
63 22nd of 29 higher than 8 of 29 other Eczema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eczema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Flourish: Exploring the Early Infant Gut Microbiome
RECRUITING · NA
-
Infant Restore: Efficacy of Microbiome Analysis and Education
ACTIVE NOT RECRUITING · NA
-
Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis
COMPLETED · NA
-
Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy
COMPLETED · NA
-
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
RECRUITING · Phase 3
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI